CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 38.02
+2.02 (5.61%)
Jul 31, 2026, 3:04 PM CST
SHE:300765 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,350 | 2,158 | 1,981 | 2,539 | 2,626 | 1,850 |
Revenue Growth | 21.87% | 8.93% | -21.98% | -3.34% | 42.00% | 40.40% |
Gross Profit Gross Profit Growth | 905.03 | 819.96 | 825.52 | 1,155 | 1,133 | 807.09 |
Operating Income Operating Income Growth | -597.14 | -625.75 | -276.66 | 153.8 | 747.14 | 434.9 |
Net Income Net Income Growth | -308.08 | -241.13 | 53.73 | 434.44 | 726.28 | 393.23 |
Earnings Per Share EPS Growth | -0.22 | -0.17 | 0.04 | 0.31 | 0.54 | 0.29 |
EPS Growth | - | - | -87.65% | -42.76% | 84.73% | 15.52% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -0.04 | - | - | - |
Other Other Growth | 43.33 | 52.64 | - | - |
Biopharmaceuticals Biopharmaceuticals Growth | 256.93 | 87.8 | 34.7 | - |
Functional Foods and Raw Materials Functional Foods and Raw Materials Growth | 1,857 | 1,840 | 2,450 | 2,243 |
Total Total Growth | 2,158 | 1,981 | 2,539 | 2,626 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 978.8 | 1,366 | 1,698 | 3,770 | 2,196 | 1,658 |
Total Debt Total Debt Growth | 12.47 | 5.65 | 0.84 | 1.65 | 20.02 | 0.84 |
Net Cash (Debt) Net Cash Growth | 966.33 | 1,360 | 1,697 | 3,769 | 2,176 | 1,657 |
Net Cash Growth | -25.56% | -19.84% | -54.97% | 73.21% | 31.29% | 13.45% |
Net Cash Per Share Net Cash Per Share Growth | 0.69 | 0.98 | 1.21 | 2.70 | 1.63 | 1.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -288.41 | -195.69 | -1,235 | 721.14 | 640.72 | 292.09 |
Capital Expenditures CapEx Growth | -579.69 | -568.39 | -477.78 | -581.42 | -114.05 | -195.41 |
Free Cash Flow Free Cash Flow Growth | -868.11 | -764.08 | -1,713 | 139.72 | 526.67 | 96.67 |
Free Cash Flow Growth | - | - | - | -73.47% | 444.79% | -58.21% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 38.51% | 38.00% | 41.68% | 45.51% | 43.15% | 43.63% |
Operating Margin | -25.41% | -29.00% | -13.97% | 6.06% | 28.45% | 23.51% |
Pretax Margin | -23.10% | -25.56% | -11.17% | 10.33% | 32.41% | 25.84% |
Profit Margin | -13.11% | -11.18% | 2.71% | 17.11% | 27.65% | 21.26% |
FCF Margin | -36.94% | -35.41% | -86.47% | 5.50% | 20.05% | 5.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.020 | - | 0.020 | 0.267 | 0.069 | 0.069 |
Dividend Per Share Growth | -93.75% | - | -92.50% | 284.29% | 0% | 94.94% |
Dividend Yield | 0.06% | - | 0.07% | 0.88% | 0.97% | 1.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 689.22 | 98.69 | 13.45 | 21.30 |
Forward PE | 52.26 | 102.68 | 51.60 | 50.21 | 12.60 | - |
P/FCF Ratio | - | - | - | 306.85 | 18.54 | 86.64 |
PS Ratio | 22.53 | 23.28 | 18.69 | 16.89 | 3.72 | 4.53 |